"Unifuzol®" in Patients With Peripheral Arterial Disease

NCT03861416 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
360
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

POLYSAN Scientific & Technological Pharmaceutical Company